Dr Mohamed Abdelghani is one of the pioneers of introducing interventional psychiatry treatment modalities, including TMS, in UK clinical practice.
In 2016 he founded the first clinical TMS service in the NHS in London and South England at Camden and Islington NHS Foundation Trust and he continues to lead this service until the present time.
Through his private practice (Dyad Medical) he was the first psychiatrist in the UK to; treat a private patient using Esketamine nasal spray, offer TPS to patients suffering with Alzheimer’s disease and offer VNS in the private sector as a treatment for depression.
In 2021 he was elected as Vice President / President-elect of the Clinical TMS Society, the largest TMS professional association in the world.
Dr Abdelghani is the first person from outside the USA to be elected to this position in the society. He started his 1-year term as Vice President on 13th June 2021 and in the summer of 2022, he will start his 1-year term as President of the society.
He has served in other leadership roles in the Clinical TMS Society as he was the Secretary of the society between 2019 – 2021 and he has been on the Board of Directors since he was elected as director in 2017 (the first British psychiatrist to be elected to this position) and he was re-elected to this position in 2020.
In May 2018 he was awarded the Clinical TMS Society President’s award for his dedication, collaboration, efforts and leadership to advance the ideals of the Society. At the present time he is a member of the following committees in the Clinical TMS Society; Educational Committee, Outreach Committee, Membership Committee and Finance Committee. He gives lectures and hands-on-training both nationally and internationally on the topic of TMS, neuromodulation and interventional psychiatry treatments. He is a faculty member of the PULSES TMS training course that is delivered by the Clinical TMS Society in different countries.
He has been formally trained in TMS at two of the top TMS centres in the world; Harvard University in USA and Medical University of South Carolina (MUSC) at the hands of Prof Mark George who was the first psychiatrist to use TMS to treat depression in the early 90s.
Dr Abdelghani is actively involved in TMS clinical research with the aim of making TMS treatment more efficient and more accessible to different groups of patients. He is the London Principal Investigator for the BRIGhTMIND TMS Randomised Control Trial (RCT). When completed it is expected to be the largest TMS RCT conducted outside North America.
Dr Abdelghani has been working as a Consultant Psychiatrist in the NHS since 2013. He has been a consultant psychiatrist at Camden & Islington NHS Foundation Trust in Central London since 2014. Dr Abdelghani was the Lead Consultant Psychiatrist for the Adult ADHD Service and a Consultant Psychiatrist at the Complex Depression, Anxiety and Trauma (CDAT) service at the Trust for almost 8 years. In 2022 he decided to step down from these two positions in order to dedicate more time for his private practice. He currently works for only a day and half every week at Camden and Islington NHS Foundation Trust where he continues to lead the Neuromodulation / TMS service that he founded in 2016. Dr Abdelghani holds two clinical excellence awards from his NHS Trust for his work on improving NHS services and providing high quality care.
Dr Abdelghani completed his post-graduate psychiatric training at South London & Maudsley NHS Foundation Trust (SLaM) which is the biggest mental health trust in the UK, a centre of excellence and one of the most influential mental health organizations in the world. During his training at SLaM he worked alongside some of the most prominent professors and clinicians in the field. Dr Abdelghani worked at the National Affective Disorders Service, which was one of six national affective disorders units in the UK. After working in the National Affective Disorders service for a year he became involved in a multicentre international cutting-edge research that tested the use of Deep Brain Stimulation (DBS) to treat treatment resistant depression. He was the primary psychiatrist at King’s College London site for this study.
In 2009 he became a member of the Royal College of Psychiatrists and in 2020 he was elected as a fellow of the college as a recognition of his contribution to the field of psychiatry. In 2012 Dr Abdelghani obtained MSc in Clinical Neuroscience from King’s College London. After finishing his higher psychiatry training at SLaM he worked as a consultant psychiatrist for almost a year at the same organization before accepting a consultant psychiatrist post at Camden & Islington NHS Foundation Trust with the aim of developing special depression and adult ADHD services.
Dr Abdelghani established his private practice Dyad Medical in Harley Street in 2015 and over the last few years he became one of the prominent private psychiatrists in London and the UK.
- Clinics Name: Dyad Medical
- Google Map Location: